Beyond Medical Technologies Inc. (CSE:DOCT)
Canada
· Delayed Price · Currency is CAD 0.7900
+0.0600 (8.22%)
Jun 27, 2025, 3:57 PM EDT
CSE:DOCT Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| - | - | - | - | - | 0.21 | Upgrade
| |
Cost of Revenue | - | - | - | - | - | 0.3 | Upgrade
|
Gross Profit | - | - | - | - | - | -0.09 | Upgrade
|
Selling, General & Admin | 0.36 | 0.41 | 0.51 | 0.67 | 1.24 | 1.71 | Upgrade
|
Research & Development | - | - | - | - | - | 0.05 | Upgrade
|
Operating Expenses | 0.37 | 0.41 | 0.51 | 0.8 | 1.44 | 1.91 | Upgrade
|
Operating Income | -0.37 | -0.41 | -0.51 | -0.8 | -1.44 | -2 | Upgrade
|
Interest Expense | - | - | - | - | - | -0.02 | Upgrade
|
Interest & Investment Income | - | - | - | - | - | 0.01 | Upgrade
|
Currency Exchange Gain (Loss) | - | 0 | -0 | 0 | -0 | 0 | Upgrade
|
Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.03 | -0.04 | -0.43 | -0.05 | Upgrade
|
EBT Excluding Unusual Items | -0.41 | -0.44 | -0.55 | -0.84 | -1.87 | -2.07 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.21 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.01 | Upgrade
|
Other Unusual Items | 0.08 | 0.07 | - | - | - | -4.24 | Upgrade
|
Pretax Income | -0.33 | -0.37 | -0.55 | -0.84 | -1.87 | -6.52 | Upgrade
|
Earnings From Continuing Operations | -0.33 | -0.37 | -0.55 | -0.84 | -1.87 | -6.52 | Upgrade
|
Earnings From Discontinued Operations | 0.08 | 0.08 | -0.04 | -0.57 | -1.05 | - | Upgrade
|
Net Income | -0.25 | -0.29 | -0.6 | -1.4 | -2.91 | -6.52 | Upgrade
|
Net Income to Common | -0.25 | -0.29 | -0.6 | -1.4 | -2.91 | -6.52 | Upgrade
|
Shares Outstanding (Basic) | 10 | 8 | 8 | 8 | 8 | 5 | Upgrade
|
Shares Outstanding (Diluted) | 10 | 8 | 8 | 8 | 8 | 5 | Upgrade
|
Shares Change (YoY) | 22.76% | - | - | 4.98% | 58.82% | 20.13% | Upgrade
|
EPS (Basic) | -0.03 | -0.04 | -0.08 | -0.18 | -0.39 | -1.37 | Upgrade
|
EPS (Diluted) | -0.03 | -0.04 | -0.08 | -0.18 | -0.39 | -1.37 | Upgrade
|
Free Cash Flow | -0.1 | -0.11 | -0.53 | -0.95 | -1.4 | -2.07 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.07 | -0.12 | -0.19 | -0.44 | Upgrade
|
Gross Margin | - | - | - | - | - | -44.54% | Upgrade
|
Operating Margin | - | - | - | - | - | -960.44% | Upgrade
|
Profit Margin | - | - | - | - | - | -3125.16% | Upgrade
|
Free Cash Flow Margin | - | - | - | - | - | -991.16% | Upgrade
|
EBITDA | - | - | - | -0.77 | -1.34 | -1.93 | Upgrade
|
D&A For EBITDA | - | - | - | 0.03 | 0.1 | 0.07 | Upgrade
|
EBIT | -0.37 | -0.41 | -0.51 | -0.8 | -1.44 | -2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.